pamidronate has been researched along with tricalcium phosphate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davies, ME; Gray, AW; Jeffcott, LB | 1 |
| Bigi, A; Bracci, B; Fini, M; Panzavolta, S; Torricelli, P | 1 |
| Chowdhury, A; Karamched, SR; Nosoudi, N; Parasaram, V; Parrish, J; Siclari, S | 1 |
| Aoki, K; Nakamura, M; Saito, N; Ueda, K; Yamamoto, Y; Yudasaka, M; Zhang, M | 1 |
1 review(s) available for pamidronate and tricalcium phosphate
| Article | Year |
|---|---|
Bisphosphosphonate-calcium phosphate cement composite and its properties.
Topics: Alendronate; Animals; Biocompatible Materials; Bone Density Conservation Agents; Calcium Phosphates; Diphosphonates; Drug Carriers; Drug Delivery Systems; Etidronic Acid; Humans; Pamidronate; Zoledronic Acid | 2019 |
3 other study(ies) available for pamidronate and tricalcium phosphate
| Article | Year |
|---|---|
Generation and activity of equine osteoclasts in vitro: effects of the bisphosphonate pamidronate (APD).
Topics: Acid Phosphatase; Animals; Bone Marrow; Bone Resorption; Calcium Phosphates; Cell Death; Cells, Cultured; Diphosphonates; Dose-Response Relationship, Drug; Gene Expression Regulation; Horses; Inhibitory Concentration 50; Iodine Radioisotopes; Osteoclasts; Osteogenesis; Pamidronate; Receptors, Vitronectin; Staining and Labeling; Time Factors | 2002 |
Alendronate and Pamidronate calcium phosphate bone cements: setting properties and in vitro response of osteoblast and osteoclast cells.
Topics: Alendronate; Bone Cements; Bone Density Conservation Agents; Calcium Phosphates; Cell Differentiation; Cell Line; Cell Proliferation; Diphosphonates; Humans; Microscopy, Electron, Scanning; Osteoblasts; Osteoclasts; Pamidronate | 2009 |
Bisphosphonate type-dependent cell viability suppressive effects of carbon nanohorn-calcium phosphate-bisphosphonate nanocomposites.
Topics: Animals; Bone Neoplasms; Bone Resorption; Calcium Phosphates; Carbon; Cell Survival; Diphosphonates; Drug Carriers; Ibandronic Acid; Mice; Nanocomposites; Osteoclasts; Pamidronate; Reactive Oxygen Species; Zoledronic Acid | 2022 |